» Articles » PMID: 35884674

Facilitating Mitophagy Via Pink1/Parkin2 Signaling Is Essential for the Neuroprotective Effect of β-Caryophyllene Against CIR-Induced Neuronal Injury

Overview
Journal Brain Sci
Publisher MDPI
Date 2022 Jul 27
PMID 35884674
Authors
Affiliations
Soon will be listed here.
Abstract

Mitophagy is an important mechanism for maintaining mitochondrial homeostasis through elimination of damaged or dysfunctional mitochondria following cerebral ischemia-reperfusion (CIR) injury. β-Caryophyllene (BCP) is a natural sesquiterpene compound found in the essential oil of plants and has been shown to ameliorate CIR injury. However, whether BCP protects neurons from CIR injury by activating mitophagy is still unclear, and the underlying mechanism remains unknown. In the present study, a mouse neuron HT-22 cell of oxygen-glucose deprivation/reoxygenation (OGD/R) and C57BL/6 male mouse of transient middle artery occlusion followed by 24 h reperfusion (MCAO/R) were established the model of CIR injury. Our results show that BCP remarkably protected against cell death and apoptosis induced by OGD/R, and decreased neurologic injury, infarct volume, and the injury of neurons in CA1 region on MCAO/R mice. In addition, BCP accelerated mitophagy by regulating expression of mitochondrial autophagy marker molecules and the mt-Atp6/Rpl13 ratio (reflecting the relative number of mitochondria), and promoting autophagosome formation compared with OGD/R and MCAO/R groups both in vitro and in vivo. Furthermore, this study revealed that BCP pre-treatment could activate the Pink1/Parkin2 signaling pathway, also with mitophagy activation. To explore the mechanisms, mitochondrial division inhibitor-1 (Mdivi-1) was used to investigate the role of BCP in CIR injury. We found that Mdivi-1 not only decreased BCP-induced facilitation of mitophagy, but also significantly weakened BCP-induced protection against OGD/R and MCAO/R models, which was consistent with levels of Pink1/Parkin2 signaling pathway. Taken together, these results suggest that facilitating mitophagy via Pink1/Parkin2 signaling is essential for the neuroprotective effect of BCP against CIR injury.

Citing Articles

Investigating the link between microplastic exposure (benzyl butyl phthalate) and neurodegenerative diseases using high-performance computational toxicology.

Abdulrahman A Toxicol Res (Camb). 2025; 14(1):tfae211.

PMID: 39830890 PMC: 11741681. DOI: 10.1093/toxres/tfae211.


Exploring β-caryophyllene: a non-psychotropic cannabinoid's potential in mitigating cognitive impairment induced by sleep deprivation.

Lim C, Ogawa S, Kumari Y Arch Pharm Res. 2024; 48(1):1-42.

PMID: 39653971 DOI: 10.1007/s12272-024-01523-z.


Role of traditional Chinese medicine monomers in cerebral ischemia/reperfusion injury:a review of the mechanism.

Zheng T, Jiang T, Huang Z, Ma H, Wang M Front Pharmacol. 2023; 14:1220862.

PMID: 37654609 PMC: 10467294. DOI: 10.3389/fphar.2023.1220862.

References
1.
Wu M, Gu X, Ma Z . Mitochondrial Quality Control in Cerebral Ischemia-Reperfusion Injury. Mol Neurobiol. 2021; 58(10):5253-5271. DOI: 10.1007/s12035-021-02494-8. View

2.
du Toit A, Hofmeyr J, Gniadek T, Loos B . Measuring autophagosome flux. Autophagy. 2018; 14(6):1060-1071. PMC: 6103398. DOI: 10.1080/15548627.2018.1469590. View

3.
Wu X, Li X, Liu Y, Yuan N, Li C, Kang Z . Hydrogen exerts neuroprotective effects on OGD/R damaged neurons in rat hippocampal by protecting mitochondrial function via regulating mitophagy mediated by PINK1/Parkin signaling pathway. Brain Res. 2018; 1698:89-98. DOI: 10.1016/j.brainres.2018.06.028. View

4.
Zhang Q, An R, Tian X, Yang M, Li M, Lou J . β-Caryophyllene Pretreatment Alleviates Focal Cerebral Ischemia-Reperfusion Injury by Activating PI3K/Akt Signaling Pathway. Neurochem Res. 2017; 42(5):1459-1469. DOI: 10.1007/s11064-017-2202-3. View

5.
Ye F, Li X, Li F, Li J, Chang W, Yuan J . Cyclosporin A protects against Lead neurotoxicity through inhibiting mitochondrial permeability transition pore opening in nerve cells. Neurotoxicology. 2016; 57:203-213. DOI: 10.1016/j.neuro.2016.10.004. View